Skip to main content
. 2005 Nov 28;102(49):17739–17744. doi: 10.1073/pnas.0503976102

Table 1. Patients.

Patient Age, years Methylation, % Parity BMI Menopause Surgery
1 17 15.0 G090 31.0 No Ovarian CA
2 32 27.1 G2P2 24.5 No Cervical CA
3 33 15.8 G5P5 27.3 No Cervical CA
4 36 30.9 G7P5 48.2 No Dysmenorrhea
5 38 35.0 G0P0 24.7 No Rectal CA
6 40 43.8 G4P4 31.7 No Myoma
7 42 43.4 G2P2 21.5 No Myoma
8 43 23.4 G3P0 24.4 No Dysmenorrhea
9 43 46.9 G2P0 25.9 Yes Ovarian CA
10 46 35.5 G0P0 19.4 No Dysmenorrhea
11 46 50.8 G1P1 21.2 No Ovarian CA
12 46 43.8 G10P7 30.5 No Prolapse
13 53 53.1 G3P2 40.6 Yes Myoma
14 54 58.4 G2P2 26.3 No Ovarian CA
15 55 47.9 G8P8 25.6 Yes Cervical CA
16 56 47.0 G10P7 23.7 No Prolapse
17 58 74.0 G1P1 30.3 Yes Dermoid Cyst
18 59 53.1 G3P2 22.1 Yes Myoma
19 64 42.4 G4P4 19.4 Yes Sarcoma
20 65 46.5 G4P4 27.7 Yes Ovarian CA
21 65 53.9 G8P2 37.0 Yes Sarcoma
22 66 66.4 G0P0 37.4 Yes Bladder CA
23 66 43.8 G4P4 25.5 Yes Cervical CA
24 70 28.5 G4P4 22.7 Yes Bladder CA
25 72 38.7 G2P2 41.2 Yes Myoma
26 78 71.5 G3P3 24.7 Yes Bladder CA
27 81 52.3 G2P2 34.6 Yes Bladder CA
28 81 38.3 G4P4 15.6 Yes Bladder CA
29 85 44.5 G12P11 20.4 Yes Cervical CA
30 87 51.6 G2P2 30.1 Yes Bladder CA

G, gravida (times pregnant); P, parity (live births); CA, carcinoma.